share_log

Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M

Benzinga Real-time News ·  Oct 3, 2022 07:31
Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment